36460 Federal Register / Vol. 87, No. 117 / Friday, June 17, 2022 / Notices 

1See Barium Chloride from India: Initiation of 

Countervailing Duty Investigation, 87 FR 7094 

(February 8, 2022) (Initiation Notice). 

2See Barium Chloride from India: Postponement 

of Preliminary Determination in the Countervailing 

Duty Investigation, 87 FR 14508 (March 15, 2022). 

3See Memorandum, ‘‘Decision Memorandum for 

the Preliminary Affirmative Determination in the 

Countervailing Duty Investigation of Barium 

Chloride from India,’’ dated concurrently with, and 

hereby adopted by, this notice (Preliminary 

Decision Memorandum). 

4See Antidumping Duties; Countervailing Duties, 

Final Rule, 62 FR 27296, 27323 (May 19, 1997). 

5See Initiation Notice. 

6See sections 771(5)(B) and (D) of the Act 

regarding financial contribution; section 771(5)(E) 

of the Act regarding benefit; and section 771(5A) of 

the Act regarding specificity. 

7See sections 776(a) and (b) of the Act. 

8See Petitioner’s Letter, ‘‘Countervailing Duty 

Investigation of Barium Chloride from India: 

Request to Align Final CVD Determination with 

Final AD Determination,’’ dated April 6, 2022. 

March 31, 2022 Notice of New 

System of Record. 

Jennifer Goode, 

Department of Commerce, Deputy Director 

and Acting Chief Privacy Officer and Director 

of the Office of Privacy and Open 

Government. 

[FR Doc. 2022–12569 Filed 6–16–22; 8:45 am] 

BILLING CODE 3510–22–P 

DEPARTMENT OF COMMERCE 

Foreign-Trade Zones Board 

[B–04–2022] 

Foreign-Trade Zone (FTZ) 177— 

Evansville, Indiana; Authorization of 

Production Activity; AstraZeneca 

Pharmaceuticals, LP (Pharmaceutical 

Products); Mount Vernon, Indiana 

On February 14, 2022, AstraZeneca 

Pharmaceuticals, LP submitted a 

notification of proposed production 

activity to the FTZ Board for its facility 

within FTZ Subzone 177A, in Mount 

Vernon, Indiana. 

The notification was processed in 

accordance with the regulations of the 

FTZ Board (15 CFR part 400), including 

notice in the Federal Register inviting 

public comment (87 FR 10332–10333, 

February 24, 2022). On June 14, 2022, 

the applicant was notified of the FTZ 

Board’s decision that no further review 

of the activity is warranted at this time. 

The production activity described in the 

notification was authorized, subject to 

the FTZ Act and the FTZ Board’s 

regulations, including Section 400.14. 

Dated: June 14, 2022. 

Andrew McGilvray, 

Executive Secretary. 

[FR Doc. 2022–13065 Filed 6–16–22; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

International Trade Administration 

[C–533–909] 

Barium Chloride From India: 

Preliminary Affirmative Countervailing 

Duty Determination and Alignment of 

Final Determination With Final 

Antidumping Duty Determination 

AGENCY: Enforcement and Compliance, 

International Trade Administration, 

Department of Commerce. 

SUMMARY: The U.S. Department of 

Commerce (Commerce) preliminarily 

determines that countervailable 

subsidies are being provided to 

producers and exporters of barium 

chloride from India. The period of 

investigation is January 1, 2021, through 

December 31, 2021. Interested parties 

are invited to comment on this 

preliminary determination. 

DATES: Applicable June 17, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Tyler Weinhold or Harrison Tanchuck, 

AD/CVD Operations, Office VI, 

Enforcement and Compliance, 

International Trade Administration, 

U.S. Department of Commerce, 1401 

Constitution Avenue NW, Washington, 

DC 20230; telephone: (202) 482–1221 or 

(202) 482–7421, respectively. 

SUPPLEMENTARY INFORMATION: 

Background 

This preliminary determination is 

made in accordance with section 703(b) 

of the Tariff Act of 1930, as amended 

(the Act). Commerce published the 

notice of initiation of this investigation 

on February 8, 2022.1 On March 15, 

2022, Commerce postponed the 

preliminary determination of this 

investigation until June 13, 2022.2 For a 

complete description of the events that 

followed the initiation of this 

investigation, see the Preliminary 

Decision Memorandum.3 A list of topics 

discussed in the Preliminary Decision 

Memorandum is included as Appendix 

II to this notice. The Preliminary 

Decision Memorandum is a public 

document and is on file electronically 

via Enforcement and Compliance’s 

Antidumping and Countervailing Duty 

Centralized Electronic Service System 

(ACCESS). ACCESS is available to 

registered users at https://

access.trade.gov. In addition, a complete 

version of the Preliminary Decision 

Memorandum can be accessed directly 

at https://access.trade.gov/public/ 

FRNoticesListLayout.aspx. 

Scope of the Investigation 

The product covered by this 

investigation is barium chloride from 

India. For a complete description of the 

scope of this investigation, see 

Appendix I. 

Scope Comments 

In accordance with the preamble to 

Commerce’s regulations,4 the Initiation 

Notice set aside a period of time for 

parties to raise issues regarding product 

coverage, (i.e., scope).5 Certain 

interested parties commented on the 

scope of the investigation as it appeared 

in the Initiation Notice. We intend to 

issue our preliminary decision regarding 

the scope of the antidumping duty (AD) 

and countervailing duty (CVD) 

investigations on or before the 

preliminary determination of the 

companion AD investigation, the 

deadline for which is August 10, 2022. 

We will incorporate the scope decisions 

from the AD investigation into the scope 

of the final CVD determination for this 

investigation, after considering any 

relevant comments submitted in scope 

case and rebuttal briefs. 

Methodology 

Commerce is conducting this 

investigation in accordance with section 

701 of the Act. For each of the subsidy 

programs found countervailable, 

Commerce preliminarily determines 

that there is a subsidy, i.e., a financial 

contribution by an ‘‘authority’’ that 

gives rise to a benefit to the recipient, 

and that the subsidy is specific.6

Commerce notes that, in making these 

findings, it relied, in part, on facts 

available and, because it finds that one 

or more respondents did not act to the 

best of their ability to respond to 

Commerce’s requests for information, it 

drew an adverse inference where 

appropriate in selecting from among the 

facts otherwise available.7 For further 

information, see the ‘‘Use of Facts 

Otherwise Available and Adverse 

Inferences’’ section in the Preliminary 

Decision Memorandum. 

Alignment 

As noted in the Preliminary Decision 

Memorandum, in accordance with 

section 705(a)(1) of the Act and 19 CFR 

351.210(b)(4), Commerce is aligning the 

final CVD determination in this 

investigation with the final 

determination in the companion AD 

investigation of barium chloride from 

India based on a request made by the 

petitioner.8 Consequently, the final CVD 

determination will be issued on the 

same date as the final AD 

determination, which is currently 


lotter on DSK11XQN23PROD with NOTICES1